首页> 外文期刊>Retina >Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
【24h】

Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.

机译:糖尿病性增生性视网膜病变患者联合23线无玻璃体玻璃体切除术和透明角膜超声乳化术。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the results and complications of combined 23-gauge sutureless vitrectomy, clear corneal phacoemulsification, and intraocular lens implantation in patients with proliferative diabetic retinopathy. METHODS: This was a retrospective, consecutive, noncomparative, interventional case series of 136 eyes of 108 patients who underwent combined sutureless vitrectomy and clear corneal cataract surgery for the complications of proliferative diabetic retinopathy. The main outcome measures were visual outcomes and surgical complications. RESULTS: Main indications for the combined surgery were vitreous hemorrhage (78 eyes, 57.4%) and tractional retinal detachment (36 eyes, 28.7%). The logarithm of the minimum angle of resolution visual acuity (mean +/- SD) improved from 0.86 +/- 0.59 preoperatively to 0.39 +/- 0.52 six months postoperatively (P < 0.0001). Intraoperative retinal tear occurred in 7 eyes (5.1%) and postoperative vitreous hemorrhage in 10 eyes (7.5%). Even in the absence of suturing of sclerotomy sites, only 1 eye (0.7%) had postoperative hypotony (<6 mmHg). During the 6 months after surgery, only 1 eye (0.7%) developed neovascular glaucoma and 6 eyes (4.4%) required a repeat vitrectomy (3 for retinal detachment and 3 for vitreous hemorrhage). CONCLUSION: Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy was safe and effective. It may have not only the known advantages of conventional combined surgery but also additionally those such as faster visual rehabilitation and less conjunctival fibrosis.
机译:目的:评估增生性糖尿病视网膜病变患者联合23线无玻璃体玻璃体切割术,透明角膜超声乳化术和人工晶状体植入术的结果和并发症。方法:这是一项回顾性,连续性,非对照性,介入性病例系列研究,对108例因增生性糖尿病性视网膜病变并发症而行无缝玻璃体切除术和透明角膜白内障手术的患者的136只眼进行了回顾性研究。主要结局指标是视觉结局和手术并发症。结果:合并手术的主要指征是玻璃体出血(78眼,57.4%)和牵引性视网膜脱离(36眼,28.7%)。分辨力敏锐度最小角度的对数(平均值+/- SD)从术前的0.86 +/- 0.59提高到术后六个月的0.39 +/- 0.52(P <0.0001)。术中发生视网膜裂孔7眼(5.1%),术后玻璃体出血10眼(7.5%)。即使没有巩膜切开术部位的缝合,也只有1只眼(0.7%)具有术后低渗(<6 mmHg)。在手术后的6个月中,只有1眼(0.7%)发生了新生血管性青光眼,6眼(4.4%)需要进行再次玻璃体切除术(3例为视网膜脱离,3例为玻璃体出血)。结论:23线无玻璃体玻璃体切割联合透明性角膜超声乳化术治疗增生性糖尿病性视网膜病变是安全有效的。它不仅具有常规联合手术的已知优点,而且还具有诸如更快的视觉康复和更少的结膜纤维化等优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号